Kirill Tremasov, an advisor to the governor of Russia’s central bank, stated that the bank will have a clearer view of lending trends by its April meeting. For now, he noted, it is too early to draw conclusions.
Despite a slowdown in credit growth in early 2025, Tremasov highlighted that a "strong fiscal impulse" has helped counterbalance the decline. Consumer and corporate lending stalled during the winter months, yet money supply dynamics have remained largely unchanged.
The key reason, according to Tremasov, is the additional flow of funds into the economy through the budget deficit. While lending activity has temporarily paused, government spending continues to inject liquidity into the financial system, preventing a sharp contraction.
He cautioned that lending data will remain distorted until April due to seasonal variations and other influencing factors. The central bank will continue monitoring these trends before making decisions on interest rates.
The Russian economy remains under close scrutiny, with analysts watching how credit activity and fiscal policies shape monetary policy decisions.


Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
RBA Raises Cash Rate to 4.10% in Closest Vote Since Transparent Voting Began
ANZ and Westpac Forecast Two RBA Rate Hikes in March and May 2026
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Bank of Japan Holds Rates Steady Amid Iran War Inflation Fears
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence 



